NCT02175017 - ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer | Biotech Hunter

Enrollment

104

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

February 28, 2021

Conditions

Advanced Non-small Cell Lung Cancer (NSCLC)

Interventions

DRUG

ONO-4538

ONO-4538 Study in Patients With Squamous NSCLC

DRUG

ONO-4538

ONO-4538 Study in Patients With Non-Squamous NSCLC

Trial Locations (10)

Goyang-si Clinical Site 103, Goyang-si

Seongnam-si Clinical Site 104, Seongnam-si

Cheongju-si Clinical Site 106, Cheongju-si

Incheon Clinical Site 102, Incheon

Seoul Clinical Site 101, Seoul

Seoul Clinical Site 107, Seoul

Seoul Clinical Site 108, Seoul

Seoul Clinical Site 109, Seoul

Seoul Clinical Site 110, Seoul

Ulsan Clinical Site 105, Ulsan